SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, et al. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 2005; 52: 41220.
  • 2
    Nicola PJ, Crowson CS, Maradit-Kremers H, Ballman KV, Roger VL, Jacobsen SJ, et al. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 2006; 54: 607.
  • 3
    Fukuta H, Little WC. Diagnosis of diastolic heart failure. Curr Cardiol Rep 2007; 9: 2248.
  • 4
    Achong N, Wahi S, Marwick TH. Evolution and outcome of diastolic dysfunction. Heart 2009; 95: 8138.
  • 5
    Yturralde RF, Gaasch WH. Diagnostic criteria for diastolic heart failure. Prog Cardiovasc Dis 2005; 47: 3149.
  • 6
    De Simone G, Kitzman DW, Palmieri V, Liu JE, Oberman A, Hopkins PN, et al. Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: the HyperGEN study. Am J Hypertens 2004; 17: 82833.
  • 7
    Lim YH, Lee JU, Kim KS, Kim SG, Kim JH, Lim HK, et al. Association between inappropriateness of left ventricular mass and left ventricular diastolic dysfunction: a study using the tissue Doppler parameter, e/e′. Korean Circ J 2009; 39: 13844.
  • 8
    Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure. Part I. Diagnosis, prognosis, and measurements of diastolic function. Circulation 2002; 105: 138793.
  • 9
    Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194202.
  • 10
    Halley CM, Houghtaling PL, Khalil MK, Thomas JD, Jaber WA. Mortality rate in patients with diastolic dysfunction and normal systolic function. Arch Intern Med 2011; 171: 10827.
  • 11
    Kane GC, Karon BL, Mahoney DW, Redfield MM, Roger VL, Burnett JC Jr, et al. Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA 2011; 306: 85663.
  • 12
    Davis JM III, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, et al. A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis. Arthritis Rheum 2011; 63: 1497506.
  • 13
    Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al, for the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283: 200812.
  • 14
    Kaminski G, Cholewa M, Tlustochowicz W, Cwetsch A, Skrobowski A, Dziuk M. Left ventricular function in rheumatoid arthritis patients. Pol Merkur Lekarski 2003; 14: 3315. In Polish.
  • 15
    Lascano C, Alba P, Gobbi C, Videla F, Campos F, Sosa H, et al. Ventricular diastolic dysfunction in rheumatoid arthritis. Rev Fac Cien Med Univ Nac Cordoba 2009; 66: 5865. In Spanish.
  • 16
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 17
    Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone. J Am Coll Cardiol 1997; 30: 818.
  • 18
    Galderisi M. Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects. Cardiovasc Ultrasound 2005; 3: 9.
  • 19
    Wells G, Shea B, O'Connel D, Peterson J, Welch J, Loso M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. 2011. URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  • 20
    Crowson CS, Myasoedova E, Davis JM III, Roger VL, Karon BL, Borgeson D, et al. Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease. Arthritis Care Res (Hoboken) 2011; 63: 72934.
  • 21
    Liang KP, Myasoedova E, Crowson CS, Davis JM, Roger VL, Karon BL, et al. Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis 2010; 69: 166570.
  • 22
    Birdane A, Korkmaz C, Ata N, Cavusoglu Y, Kasifoglu T, Dogan SM, et al. Tissue Doppler imaging in the evaluation of the left and right ventricular diastolic functions in rheumatoid arthritis. Echocardiography 2007; 24: 48593.
  • 23
    Rexhepaj N, Bajraktari G, Berisha I, Beqiri A, Shatri F, Hima F, et al. Left and right ventricular diastolic functions in patients with rheumatoid arthritis without clinically evident cardiovascular disease. Int J Clin Pract 2006; 60: 6838.
  • 24
    Levendoglu F, Temizhan A, Ugurlu H, Ozdemir A, Yazici M. Ventricular function abnormalities in active rheumatoid arthritis: a Doppler echocardiographic study. Rheumatol Int 2004; 24: 1416.
  • 25
    Alpaslan M, Onrat E, Evcik D. Doppler echocardiographic evaluation of ventricular function in patients with rheumatoid arthritis. Clin Rheumatol 2003; 22: 848.
  • 26
    Marasovic-Krstulovic D, Martinovic-Kaliterna D, Fabijanic D, Morovic-Vergles J. Are the anti-cyclic citrullinated peptide antibodies independent predictors of myocardial involvement in patients with active rheumatoid arthritis? Rheumatology (Oxford) 2011; 50: 150512.
  • 27
    Rudominer RL, Roman MJ, Devereux RB, Paget SA, Schwartz JE, Lockshin MD, et al. Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum 2009; 60: 229.
  • 28
    Bangalore S, Yao SS, Chaudhry FA. Role of left atrial size in risk stratification and prognosis of patients undergoing stress echocardiography. J Am Coll Cardiol 2007; 50: 125462.
  • 29
    Yavuzkir M, Ozturk A, Dagli N, Koca S, Karaca I, Balin M, et al. Effect of ongoing inflammation in rheumatoid arthritis on P-wave dispersion. J Int Med Res 2007; 35: 796802.
  • 30
    Guler H, Seyfeli E, Sahin G, Duru M, Akgul F, Saglam H, et al. P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters. Rheumatol Int 2007; 27: 8138.
  • 31
    Hebbar P, Deshmukh A, Xiong W, Paydak H. Association of atrial fibrillation with rheumatoid arthritis and systemic lupus erythematosus [abstract]. Heart Rhythm 2011; 8: S310.
  • 32
    Lindhardsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Svendsen JH, et al. Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ 2012; 344: e1257.
  • 33
    Shariff N, Kumar A, Narang R, Malhotra A, Mukhopadhyaya S, Sharma SK. A study of pulmonary arterial hypertension in patients with rheumatoid arthritis [letter]. Int J Cardiol 2007; 115: 756.
  • 34
    Udayakumar N, Venkatesan S, Rajendiran C. Pulmonary hypertension in rheumatoid arthritis: relation with the duration of the disease. Int J Cardiol 2008; 127: 4102.
  • 35
    Morris DA, Gailani M, Vaz Perez A, Blaschke F, Dietz R, Haverkamp W, et al. Right ventricular myocardial systolic and diastolic dysfunction in heart failure with normal left ventricular ejection fraction. J Am Soc Echocardiogr 2011; 24: 88697.
  • 36
    Seyfeli E, Guler H, Akoglu S, Karazincir S, Akgul F, Saglam H, et al. Right ventricular diastolic abnormalities in rheumatoid arthritis and its relationship with left ventricular and pulmonary involvement: a tissue Doppler echocardiographic study. Int J Cardiovasc Imaging 2006; 22: 74554.
  • 37
    Correa de Sa DD, Hodge DO, Slusser JP, Redfield MM, Simari RD, Burnett JC, et al. Progression of preclinical diastolic dysfunction to the development of symptoms. Heart 2010; 96: 52832.
  • 38
    Yazici D, Tokay S, Aydin S, Toprak A, Inanc N, Khan SR, et al. Echocardiographic evaluation of cardiac diastolic function in patients with rheumatoid arthritis: 5 years of follow-up. Clin Rheumatol 2008; 27: 64750.
  • 39
    Hassanein A, Desai A, Verma A, Oparil S, Izzo J, Rocha R, et al. EXCEED: exforge-intensive control of hypertension to evaluate efficacy in diastolic dysfunction. Study rationale, design, and participant characteristics. Ther Adv Cardiovasc Dis 2009; 3: 42939.
  • 40
    Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol 2001; 37: 10428.
  • 41
    Rajaram V, Evans AT, Caldito GC, Kelly RF, Fogelfeld L, Black HR, et al. High sensitivity C-reactive protein is associated with diastolic dysfunction in young African Americans without clinically evident cardiac disease. Open Cardiovasc Med J 2011; 5: 18895.
  • 42
    Corrao S, Scaglione R, Calvo L, Licata G. A meta-analysis of the effect size of rheumatoid arthritis on left ventricular mass: comment on the article by Rudominer et al [letter]. Arthritis Rheum 2009; 60: 28512.
  • 43
    Giles JT, Malayeri AA, Fernandes V, Post W, Blumenthal RS, Bluemke D, et al. Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Arthritis Rheum 2010; 62: 94051.
  • 44
    Koivuniemi R, Paimela L, Suomalainen R, Tornroth T, Leirisalo-Repo M. Amyloidosis is frequently undetected in patients with rheumatoid arthritis. Amyloid 2008; 15: 2628.
  • 45
    Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010; 376: 1094108.
  • 46
    He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001; 161: 9961002.
  • 47
    Ouzounian M, Lee DS, Liu PP. Diastolic heart failure: mechanisms and controversies. Nat Clin Pract Cardiovasc Med 2008; 5: 37586.
  • 48
    Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83: 184965.
  • 49
    CDC, National Center for Health Statistics. Health Data Interactive: hypertension, ages 20+, US, 1998-2010. URL: www.cdc.gov/nchs/hdi.htm.
  • 50
    Regitz-Zagrosek V, Brokat S, Tschope C. Role of gender in heart failure with normal left ventricular ejection fraction. Prog Cardiovasc Dis 2007; 49: 24151.
  • 51
    Van den Hondel KE, Eijgelsheim M, Ruiter R, Witteman JC, Hofman A, Stricker BH. Effect of short-term NSAID use on echocardiographic parameters in elderly people: a population-based cohort study. Heart 2011; 97: 5403.
  • 52
    Sitia S, Tomasoni L, Cicala S, Atzeni F, Ricci C, Gaeta M, et al. Detection of preclinical impairment of myocardial function in rheumatoid arthritis patients with short disease duration by speckle tracking echocardiography. Int J Cardiol 2012; 160: 814.
  • 53
    Abdul Muizz AM, Mohd Shahrir MS, Sazliyana S, Oteh M, Shamsul AS, Hussein H. A cross-sectional study of diastolic dysfunction in rheumatoid arthritis and its association with disease activity. Int J Rheum Dis 2011; 14: 1830.
  • 54
    Acar G, Sayarlioglu M, Akcay A, Sokmen A, Sokmen G, Yalcintas S, et al. Evaluation of atrial electromechanical delay and left atrial mechanical functions in patients with rheumatoid arthritis. Turk Kardiyol Dern Ars 2009; 37: 44753.
  • 55
    Wislowska M, Jaszczyk B, Kochmanski M, Sypula S, Sztechman M. Diastolic heart function in RA patients. Rheumatol Int 2008; 28: 5139.
  • 56
    Udayakumar N, Venkatesan S, Rajendiran C. Diastolic function abnormalities in rheumatoid arthritis: relation with duration of disease. Singapore Med J 2007; 48: 53742.
  • 57
    Meune C, Wahbi K, Assous N, Weber S, Kahan A, Allanore Y. Myocardial dysfunction in rheumatoid arthritis: a controlled tissue-Doppler echocardiography study. J Rheumatol 2007; 34: 20059.
  • 58
    Canturk F, Yazici M, Alayli G, Menekse EB, Demircan S, Ibrahimli F, et al. Combined use of propagation velocity and intraventricular dispersion of E wave velocity for the evaluation of diastolic functions in patients with rheumatoid arthritis. Int J Cardiovasc Imaging 2006; 22: 36976.
  • 59
    Arslan S, Bozkurt E, Sari RA, Erol MK. Diastolic function abnormalities in active rheumatoid arthritis evaluation by conventional Doppler and tissue Doppler: relation with duration of disease. Clin Rheumatol 2006; 25: 2949.
  • 60
    Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Ollier WE, et al. Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum 2004; 33: 2318.
  • 61
    Di Franco M, Paradiso M, Mammarella A, Paoletti V, Labbadia G, Coppotelli L, et al. Diastolic function abnormalities in rheumatoid arthritis: evaluation by echo Doppler transmitral flow and pulmonary venous flow. Relation with duration of disease. Ann Rheum Dis 2000; 59: 2279.
  • 62
    Montecucco C, Gobbi G, Perlini S, Rossi S, Grandi AM, Caporali R, et al. Impaired diastolic function in active rheumatoid arthritis: relationship with disease duration. Clin Exp Rheumatol 1999; 17: 40712.
  • 63
    Wislowska M, Sypula S, Kowalik I. Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker's criteria, functional index, value of Waaler-Rose titre and duration of disease. Clin Rheumatol 1998; 17: 36977.
  • 64
    Corrao S, Salli L, Arnone S, Scaglione R, Pinto A, Licata G. Echo-Doppler left ventricular filling abnormalities in patients with rheumatoid arthritis without clinically evident cardiovascular disease. Eur J Clin Invest 1996; 26: 2937.
  • 65
    Mustonen J, Laakso M, Hirvonen T, Mutru O, Pirnes M, Vainio P, et al. Abnormalities in left ventricular diastolic function in male patients with rheumatoid arthritis without clinically evident cardiovascular disease. Eur J Clin Invest 1993; 23: 24653.
  • 66
    Maione S, Valentini G, Giunta A, Tirri R, Giacummo A, Lippolis C, et al. Cardiac involvement in rheumatoid arthritis: an echocardiographic study. Cardiology 1993; 83: 2349.